Your browser doesn't support javascript.
loading
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.
Özdemir, Özlem; Zengel, Baha; Yildiz, Yasar; Uluç, Basak Oyan; Cabuk, Devrim; Ozden, Ercan; Salim, Derya Kivrak; Paydas, Semra; Demir, Atakan; Diker, Omer; Pilanci, Kezban Nur; Sönmez, Özlem Uysal; Vatansever, Sezai; Dogan, Izzet; Gulmez, Ahmet; Cakar, Burcu; Gursoy, Pinar; Yildirim, Mahmut Emre; Ayhan, Murat; Karadurmus, Nuri; Aykan, Musa Baris; Cevik, Gökcen Tugba; Sakalar, Teoman; Hacibekiroglu, Ilhan; Gülbagci, Burcu Belen; Dincer, Murat; Garbioglu, Duygu Bayir; Kemal, Yasemin; Nayir, Erdinc; Taskaynatan, Halil; Yilmaz, Mesut; Avci, Okan; Sari, Murat; Coban, Ezgi; Atci, Muhammed Mustafa; Esen, Selin Aktürk; Telli, Tugba Akin; Karatas, Fatih; Inal, Ali; Demir, Hacer; Kalkan, Nurhan Onal; Yilmaz, Cengiz; Tasli, Funda; Alacacioglu, Ahmet.
Afiliación
  • Özdemir Ö; Departments of Medical Oncology.
  • Zengel B; General Surgery, Bozyaka Training and Research Hospital.
  • Yildiz Y; Department Medical of Oncology, Katip Çelebi University, Atatürk Training and Research Hospital, Izmir.
  • Uluç BO; Department of Medical Oncology, Acibadem Hospital, Istanbul.
  • Cabuk D; Department of Medical Oncology, Kocaeli University Faculty of Medicine Hospital, Kocaeli.
  • Ozden E; Department of Medical Oncology, Kocaeli University Faculty of Medicine Hospital, Kocaeli.
  • Salim DK; Department of Medical Oncology, Health Sciences University Antalya Training and Research Hospital, Antalya.
  • Paydas S; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey.
  • Demir A; Department of Medical Oncology, Acibadem Hospital, Istanbul.
  • Diker O; Department of Medical Oncology, Near East University Hospital, Lefkosa, Cyprus.
  • Pilanci KN; Department of Medical Oncology, Memorial Bahcelievler Hospital.
  • Sönmez ÖU; Department of Medical Oncology, Acibadem Hospital, Istanbul.
  • Vatansever S; Department of Medical Oncology, Istanbul University Faculty of Medicine, Istanbul.
  • Dogan I; Department of Medical Oncology, Istanbul University Faculty of Medicine, Istanbul.
  • Gulmez A; Department of Medical Oncology, Inonu University Faculty of Medicine, Malatya.
  • Cakar B; Department of Medical Oncology, Ege University Faculty of Medicine, Izmir.
  • Gursoy P; Department of Medical Oncology, Ege University Faculty of Medicine, Izmir.
  • Yildirim ME; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul.
  • Ayhan M; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul.
  • Karadurmus N; Department of Medical Oncology, Health Sciences University Gulhane Training and Research Hospital, Ankara.
  • Aykan MB; Department of Medical Oncology, Health Sciences University Gulhane Training and Research Hospital, Ankara.
  • Cevik GT; Department of Medical Oncology, Usak University Training and Research Hospital, Usak.
  • Sakalar T; Department of Medical Oncology, Kahramanmaras Necip Fazil City Hospital, Kahramanmaras.
  • Hacibekiroglu I; Department of Medical Oncology, Sakarya University Training and Research Hospital, Sakarya.
  • Gülbagci BB; Department of Medical Oncology, Sakarya University Training and Research Hospital, Sakarya.
  • Dincer M; Department of Medical Oncology, Osmangazi University Faculty of Medicine Hospital, Eskisehir.
  • Garbioglu DB; Department of Medical Oncology, Osmangazi University Faculty of Medicine Hospital, Eskisehir.
  • Kemal Y; Department of Medical Oncology, Medical Park Hospital, Samsun.
  • Nayir E; Department of Medical Oncology, Medical Park Hospital, Mersin.
  • Taskaynatan H; Department of Medical Oncology, Private Ege City Hospital, Izmir.
  • Yilmaz M; Department of Medical Oncology, Bakirköy Dr. Sadi Konuk Training and Research Hospital, Istanbul.
  • Avci O; Department of Medical Oncology, Namik Kemal University Hospital, Tekirdag.
  • Sari M; Department of Medical Oncology, Haydarpasa Numune Training and Research Hospital.
  • Coban E; Department of Medical Oncology, Haydarpasa Numune Training and Research Hospital.
  • Atci MM; Department of Medical Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul.
  • Esen SA; Department of Medical Oncology, Ankara City Hospital, Ankara.
  • Telli TA; Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul.
  • Karatas F; Department of Medical Oncology, Karabuk University Faculty of Medicine, Karabuk.
  • Inal A; Department of Medical Oncology, Mersin City Training and Research Hospital, Mersin.
  • Demir H; Department of Medical Oncology, Afyonkarahisar Health Sciences University, Afyonkarahisar.
  • Kalkan NO; Department of Medical Oncology, Van Yuzuncu Yil Faculty of Medicine, Van.
  • Yilmaz C; Departments of Medical Oncology.
  • Tasli F; Department of Pathology, Bozyaka Training and Research Hospital, Izmir, Turkey.
  • Alacacioglu A; Department Medical of Oncology, Katip Çelebi University, Atatürk Training and Research Hospital, Izmir.
Anticancer Drugs ; 33(7): 663-670, 2022 08 01.
Article en En | MEDLINE | ID: mdl-35703239
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Intraductal no Infiltrante Tipo de estudio: Clinical_trials / Etiology_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Intraductal no Infiltrante Tipo de estudio: Clinical_trials / Etiology_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article